Related Experiment Video
Updated: Apr 13, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Endocrine therapy: defining the path of least resistance
Andrew Stone1, Elizabeth A Musgrove2
1Cancer Epigenetics Program, Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, Sydney, 2010, NSW, Australia. a.stone@garvan.org.au.
Abstract:
One of the best-characterized oncogenic mechanisms in breast cancer is the aberrant activation of phosphatidylinositol-3-kinase, protein kinase B, and mammalian target of rapamycin signaling. In both endocrine-resistant disease and breast cancer stem cells, this is commonly caused by specific genetic lesions or amplification of key pathway components or both. These observations have generated two interesting hypotheses. Firstly, do these genetic anomalies provide clinically significant biomarkers predictive of endocrine resistance? Secondly, do tamoxifen-resistant breast cancer cells emerge from a stem-like cell population? New studies, published in Breast Cancer Research, raise the possibility that these hypotheses are intrinsically linked.
Insights
Aberrant phosphatidylinositol-3-kinase signaling is common in endocrine-resistant breast cancer. New research suggests genetic anomalies in this pathway may predict resistance and link to breast cancer stem cells.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Aberrant activation of the phosphatidylinositol-3-kinase (PI3K), protein kinase B (PKB), and mammalian target of rapamycin (mTOR) signaling pathway is a hallmark of many cancers, including breast cancer.
- This pathway dysregulation is frequently observed in endocrine-resistant breast cancer and breast cancer stem cells, often due to specific genetic lesions or amplification of pathway components.
Discussion:
- The study explores two key hypotheses: whether genetic anomalies in the PI3K/PKB/mTOR pathway serve as predictive biomarkers for endocrine resistance in breast cancer, and if tamoxifen-resistant breast cancer cells originate from a stem-like cell population.
- These hypotheses are investigated in the context of recent findings published in Breast Cancer Research, suggesting a potential intrinsic link between them.
Key Insights:
- Genetic lesions or amplification within the PI3K/PKB/mTOR pathway are implicated in both endocrine resistance and breast cancer stem cell populations.
- The research raises the possibility that these genetic anomalies could serve as predictive biomarkers for endocrine resistance.
- A potential link is proposed between the emergence of tamoxifen-resistant breast cancer cells and the stem-like cell population.
Outlook:
- Further investigation is warranted to validate the predictive value of PI3K/PKB/mTOR pathway genetic anomalies as biomarkers for endocrine resistance.
- Understanding the relationship between these genetic alterations, stem-like cells, and tamoxifen resistance could lead to novel therapeutic strategies for difficult-to-treat breast cancers.
- This research opens avenues for developing targeted therapies aimed at overcoming endocrine resistance by targeting the PI3K/PKB/mTOR pathway and associated stem cell characteristics.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Regulation of Hormone Secretion
Humoral...
Chemical Signaling in the Endocrine System
Lipid-soluble hormones, such as steroid hormones, demonstrate an intracellular action. These hormones traverse cell membranes due to their lipid nature. Once inside the target cell, they...
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
An Overview of the Endocrine System
The endocrine system collaborates...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Endocrine Signaling